New Act Would Mean Wider Medicare Coverage of Genetic Cancer Screening
Legislation would require Medicare to cover genomic cancer testing and follow-up screening for those with a family history of cancer.
Already a member? Log in here
Single Test for Over 50 Genetic Diseases to Accelerate Diagnosis
A new DNA test, developed by researchers at the Garvan Institute of Medical Research in Sydney and collaborators from Australia, UK, and Israel, has been shown to identify a range of hard-to-diagnose neurological and neuromuscular genetic diseases quicker and...
Despite COVID-19, DTC Genetic Testing Market to Be Worth $1.9B by 2026
A new report from Global Industry Analysts Inc. predicts that the global market for direct-to-consumer (DTC) genetic testing will be worth $1.9 billion US by 2026. What Is Driving the Growth of the Genetic Testing Market? The report highlights several factors driving...
Feds Target Fraudulent Billing of Genetic Cancer Tests
False ordering and billing of cancer genetic (CGx) tests has become a favorite target for federal fraud enforcers, with the U.S. Department of Justice (DOJ) reporting two notable convictions in the closing months of 2021. On Nov. 17, a 57-year-old former lab sales rep...
Illumina Partners for Development of Next-Gen Sequencing Tests
...
Already a member? Log in here